Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04432883 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

Study acronym: AphasiatDCS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Primary completion date: Mar 27, 2026 to Mar 26, 2027 Completion date: Apr 30, 2026 to Apr 30, 2027v6 Show 1 more changeShow less
    • Completion date: Apr 30, 2026 to Apr 30, 2027
  3. Primary completion date: Dec 8, 2025 to Mar 27, 2026 Eligibility criteria revisedv5 Show 1 more changeShow less
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  4. Re-verified, no change to tracked fieldsv4
  5. Start date: Dec 1, 2016 to Oct 18, 2022 Primary completion date: May 2026 to Dec 8, 2025 · Completion date: May 2026 to Apr 30, 2026v3 Show 2 more changesShow less
    • Primary completion date: May 2026 to Dec 8, 2025
    • Completion date: May 2026 to Apr 30, 2026
  6. Primary completion date: Dec 1, 2020 to May 2026 Completion date: Dec 1, 2021 to May 2026 · Collaborators: 2 to 3v2 Show 2 more changesShow less
    • Completion date: Dec 1, 2021 to May 2026
    • Collaborators: 2 to 3

    See this version in full on ClinicalTrials.gov ↗

  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of New Mexico
46 trials monitored
See 9 trials at risk
Stroke
3,289 trials monitored
See 141 trials at risk
62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.
Trial Details
NCT Number NCT04432883
Lead Sponsor University of New Mexico
Collaborators: National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS), National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Stroke, Aphasia
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov